09.02.2017 14:48:16
|
Forward Pharma Gets $1.25 Bln On Settlement And License Deal With Biogen
(RTTNews) - Forward Pharma A/S (FWP) said that it has received a non-refundable cash fee of US$1.25 billion in connection with the execution and delivery of a Settlement and License Agreement with two wholly owned subsidiaries of Biogen Inc. and certain other parties.
On January 17, 2017 Forward entered into the License Agreement subject to the approval of its shareholders and certain other limited customary conditions. Forward obtained approval of the entry into the License Agreement by the requisite two-thirds majority of the votes cast as well as the share capital represented at an extraordinary general meeting held on February 1, 2017. The terms of the License Agreement required the US$ 1.25 billion cash fee to be paid within five business days of the Extraordinary General Meeting.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biogen Incmehr Nachrichten
17.02.25 |
NASDAQ Composite Index-Titel Biogen-Aktie: So viel hätten Anleger an einem Biogen-Investment von vor 5 Jahren verloren (finanzen.at) | |
13.02.25 |
Gewinne in New York: NASDAQ 100 legt zum Start des Donnerstagshandels zu (finanzen.at) | |
12.02.25 |
Angespannte Stimmung in New York: S&P 500 zum Handelsende schwächer (finanzen.at) | |
12.02.25 |
NASDAQ 100 aktuell: NASDAQ 100 liegt schlussendlich im Plus (finanzen.at) | |
12.02.25 |
Börse New York: Das macht der NASDAQ Composite nachmittags (finanzen.at) | |
12.02.25 |
Angespannte Stimmung in New York: S&P 500 am Mittwochnachmittag im Minus (finanzen.at) | |
12.02.25 |
Freundlicher Handel: NASDAQ 100-Anleger greifen zu (finanzen.at) | |
12.02.25 |
Börse New York: S&P 500 verbucht Abschläge (finanzen.at) |
Analysen zu Biogen Incmehr Analysen
Aktien in diesem Artikel
Biogen Inc | 134,30 | 2,68% |
|